Gritstone Oncology Gets $92.7M

Emeryville-based Gritstone Oncology, a cancer immunotherapy startup focused on personalized medicine for treating patients with non-small cell lung cancer and gastric cancer, said last week that it raised $92.7M in a Series B funding round

The story you have requested is only available to paid members of the web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.